NEW YORK (GenomeWeb) – Cancer Genetics said after the close of the market on Monday that its fourth quarter revenues rose 4 percent year over year, falling short of the consensus Wall Street estimate.

For the three months ended Dec. 31, 2017, the firm posted $7.5 million in total revenues, up from $7.2 million a year ago. On average, Wall Street had expected $9.2 million in revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.